As of January 22, 2025, Cullinan Therapeutics (CGEM) has a market cap of $0.61 billion USD. According to our data, Cullinan Therapeutics is ranked No.5863 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.61 B |
-13.71%
|
Dec 31, 2024 | $0.71 B |
19.53%
|
Dec 29, 2023 | $0.59 B |
-3.41%
|
Dec 30, 2022 | $0.61 B |
-31.63%
|
Dec 31, 2021 | $0.90 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$364.73 B |
95.429 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Roche
ROG.SW
|
$243.80 B |
38.055 B
|
Switzerland
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CSL
CSL.AX
|
$82.04 B |
-0.000 M
|
Australia
|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.56 B |
0.452 B
|
Japan
|
Market Cap | = | CGEM Stock Price | * | CGEM Shares Outstanding |
= | $10.51 | * | 58.23 M | |
= | $0.61 B |